Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Severe Clinical Phenotypes of Heterozygous Females With X-Linked Chronic Granulomatous Disease
  2. Patel, Niraj C; Younger, M Elizabeth M; Williams, Kelli; Matias Lopes, Joao Pedro; Kuhns,Doug; Patel, Meera N; Miranda, Mary Ann; Marciano, Beatriz E; Deal, Christin Lawler; Leiding, Jennifer W
  3. The journal of Allergy and Clinical Immunology. In Practice. 2024, Sep 25;
  1. 2.   Histone H3/H4 chaperone CHAF1B prevents the mislocalization of CENP-A for chromosomal stability
  2. Shrestha, Roshan L; Balachandra, Vinutha; Kim, Jee Hun; Rossi, Austin; Vadlamani, Pranathi; Sethi, Subhash Chandra; Ozbun, Laurent; Lin, Shinjen; Cheng, Ken Chin-Chien; Chari,Raj; Karpova, Tatiana S; Pegoraro, Gianluca; Foltz, Daniel R; Caplen, Natasha J; Basrai, Munira A
  3. Journal of Cell Science. 2023, May 02; 136(10):
  1. 3.   Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis
  2. Bode, C.; Kinjo, T.; Alvord, W. G.; Klinman, D. M.
  3. Carcinogenesis. 2014, May; 35(5): 1078-83.
  1. 4.   Fine mapping of 14q24.1 breast cancer susceptibility locus
  2. Lee, P.; Fu, Y. P.; Figueroa, J. D.; Prokunina-Olsson, L.; Gonzalez-Bosquet, J.; Kraft, P.; Wang, Z. M.; Jacobs, K. B.; Yeager, M.; Horner, M. J.; Hankinson, S. E.; Hutchinson, A.; Chatterjee, N.; Garcia-Closas, M.; Ziegler, R. G.; Berg, C. D.; Buys, S. S.; McCarty, C. A.; Feigelson, H. S.; Thun, M. J.; Diver, R.; Prentice, R.; Jackson, R.; Kooperberg, C.; Chlebowski, R.; Lissowska, J.; Peplonska, B.; Brinton, L. A.; Tucker, M.; Fraumeni, J. F.; Hoover, R. N.; Thomas, G.; Hunter, D. J.; Chanock, S. J.
  3. Human Genetics. 2012, Mar; 131(3): 479-490.
  1. 5.   miRNA signature associated with outcome of gastric cancer patients following chemotherapy
  2. Kim, C. H.; Kim, H. K.; Rettig, R. L.; Kim, J.; Lee, E. T.; Aprelikova, O.; Choi, I. J.; Munroe, D. J.; Green, J. E.
  3. Bmc Medical Genomics. 2011, Nov; 4
  1. 6.   The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation
  2. Weissman, A. M.; Shabek, N.; Ciechanover, A.
  3. Nature Reviews Molecular Cell Biology. 2011, Sep; 12(9): 605-620.
  1. 7.   Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH
  2. Kim, S. E.; Bahta, M.; Lountos, G. T.; Ulrich, R. G.; Burke, T. R.; Waugh, D. S.
  3. Acta Crystallographica Section D-Biological Crystallography. 2011, Jul; 67: 639-645.
  1. 8.   Utilization of Nitrophenylphosphates and Oxime-Based Ligation for the Development of Nanomolar Affinity Inhibitors of the Yersinia pestis Outer Protein H (YopH) Phosphatase
  2. Bahta, M.; Lountos, G. T.; Dyas, B.; Kim, S. E.; Ulrich, R. G.; Waugh, D. S.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2011, Apr; 54(8): 2933-2943.
  1. 9.   Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates
  2. Nwe, K.; Bernardo, M.; Regino, C. A. S.; Williams, M.; Brechbiel, M. W.
  3. Bioorganic & Medicinal Chemistry. 2010, Aug; 18(16): 5925-5931.
  1. 10.   Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
  2. Sissung, T. M.; Baum, C. E.; Kirkl, C. T.; Gao, R.; Gardner, E. R.; Figg, W. D.
  3. Molecular Biotechnology. 2010, Feb; 44(2): 152-167.
  1. 11.   A Central Role for Transcription Factor C/EBP-beta in Regulating CD1d Gene Expression in Human Keratinocytes
  2. Sikder, H.; Zhao, Y.; Balato, A.; Chapoval, A.; Fishelevich, R.; Gade, P.; Singh, I. S.; Kalvakolanu, D. V.; Johnson, P. F.; Gaspari, A. A.
  3. Journal of Immunology. 2009 183(3): 1657-1666.
  1. 12.   LIM homeobox transcription factors integrate signaling events that control three-dimensional limb patterning and growth
  2. Tzchori, I.; Day, T. F.; Carolan, P. J.; Zhao, Y.; Wassif, C. A.; Li, L.; Lewandoski, M.; Gorivodsky, M.; Love, P. E.; Porter, F. D.; Westphal, H.; Yang, Y.
  3. Development. 2009 136(8): 1375-1385.
  1. 13.   Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappa B activation
  2. Iha, H.; Peloponese, J. M.; Verstrepen, L.; Zapart, G.; Ikeda, F.; Smith, C. D.; Starost, M. F.; Yedavalli, V.; Heyninck, K.; Dikic, I.; Beyaert, R.; Jeang, K. T.
  3. Embo Journal. 2008 27(4): 629-641.
  1. 14.   BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers
  2. Yuli, C.; Shao, N.; Rao, R.; Aysola, P.; Reddy, V.; Oprea-llies, G.; Lee, L.; Okoli, J.; Partridge, E.; Reddy, E. S. P.; Rao, V. N.
  3. Oncogene. 2007, Sep; 26(41): 6031-6037.
  1. 15.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 16.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 17.   Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
  2. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 4087-4099.
  1. 18.   A one-step synthesis of N-alpha-Fmoc-4-O-[O ',O ''-di-tert-butyl-2-(2-fluoromalonyl)]-L-tyrosine from commercially available starting material
  2. Kang, S. U.; Burke, T. R.
  3. Tetrahedron Letters. 2004, NOV 15; 45(47): 8611-8613.
  1. 19.   Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker
  2. Marquez, V. E.; Ben Kasus, T.; Barchi, J. J.; Green, K. M.; Nicklaus, M. C.; Agbaria, R.
  3. Journal of the American Chemical Society. 2004 126(2): 543-549.
  1. 20.   Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level
  2. Andersen, H.; Rossio, J. L.; Coalter, V.; Poore, B.; Martin, M. P.; Carrington, M.; Lifson, J. D.
  3. Cellular Immunology. 2004, SEP-OCT; 231(1-2): 85-95.
  1. 21.   Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide
  2. Kang, S. U.; Yang, G.; Li, W.; Zhang, Z. Y.; Burke, T. R.
  3. Chemistry & Biodiversity. 2004 1(4): 626-633.
  1. 22.   Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration
  2. Liu, D. G.; Gao, Y.; Voigt, J. H.; Lee, K.; Nicklaus, M. C.; Wu, L.; Zhang, Z. Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2003 13(18): 3005-3007.
  1. 23.   Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter
  2. Chen, L. Y.; Shieh, J. J.; Lin, B. C.; Pan, C. J.; Gao, J. L.; Murphy, P. M.; Roe, T. F.; Moses, S.; Ward, J. M.; Lee, E. J.; Westphal, H.; Mansfield, B. C.; Chou, J. Y.
  3. Human Molecular Genetics. 2003 12(19): 2547-2558.
  1. 24.   Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase
  2. Lee, K.; Gao, Y.; Yao, Z. J.; Phan, J.; Wu, L.; Liang, J.; Waugh, D. S.; Zhang, Z. Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2003 13(15): 2577-2581.
  1. 25.   CD45 protein-tyrosine phosphatase inhibitor development
  2. Lee, K.; Burke, T. R.
  3. Current Topics in Medicinal Chemistry. 2003 3(7): 797-807.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel